Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro

Protein Expression and Purification

Volumn 15, Issue 1, 1999, Pages 105-114

  Frayser, Mia ^a   Sato, Aaron K ^a   Xu, Lihui ^a   Stern, Lawrence J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DICHROISM SPECTROSCOPY; DODECYL SULFATE SODIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; THERMAL DENATURATION;

ESCHERICHIA COLI;

EID: 0033084056     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1998.0987     Document Type: Article

References (48)

1. Stern L. J., Wiley D. C. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure. 15:1994;245-251.
2. Cresswell P. Assembly, transport, and function of MHC class II molecules. Ann. Rev. Immunol. 12:1994;258-293.
3. Germain R. N., Margulies D. H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:1993;403-450.
4. Gorga J. C., Horejsí V., Johnson D. R., Raghupathy R., Strominger J. L. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262:1987;16087-16094.
5. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A. A., Strominger J. L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:1992;764-768.
6. d. Science. 256:1992;1817-1820.
7. Rudensky A. Y., Preston-Hurlburt P., Al-Ramadi B. K., Rothbard J., Janeway C. A. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature. 359:1992;429-431.
8. Kozono H., White J., Clements J., Marrack P., Kappler J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature. 369:1994;151-154.
9. Stern L. J., Wiley D. C. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell. 68:1992;465-477.
10. Stöckel J., Meinl E., Hahnel C., Malotka J., Seitz R., Drexler K., Wekerle H., Dornmair K. Refolding of human class II major histocompatibility complex molecules isolated fromEscherichia coli. J. Biol. Chem. 269:1994;29571-29578.
11. Altman J. D., Reay P. A., Davis M. M. Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced inE. coli. Proc. Natl. Acad. Sci. USA. 90:1993;10330-10334.
12. Arimilli S., Cardoso C., Mukku P., Baichwal V., Nag B. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant α and β polypeptide chains. J. Biol. Chem. 270:1995;971-977.
13. Scott C. A., Garcia K. C., Carbone F. R., Wilson I. A., Teyton L. Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J. Exp. Med. 183:1996;2087-2095.
14. Wettstein D. A., Boniface J. J., Reay P. A., Schild H., Davis M. M. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex at low pH. J. Exp. Med. 174:1991;219-228.
15. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., Wiley D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215-221.
16. Fremont D. H., Hendrickson W. A., Marrack P., Kappler J. Structures of an MHC class II molecules with covalently bound single peptides. Science. 272:1996;1001-1004.
17. Sadegh-Nasseri S., Stern L. J., Wiley D. C., Germain R. N. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature. 370:1994;647-648.
18. Seth A., Stern L. J., Ottenhoff T. H. M., Engel I., Owen M. J., Lamb J. R., Klausner R. D., Wiley D. C. Binary and ternary complexes among soluble T-cell receptor, soluble class II MHC, and superantigen. Nature. 369:1994;324-327.
19. Hammer J., Valsasnini P., Tolba K., Bolin D., Higelin J., Takacs B., Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 74:1993;197-203.
20. MacFerrin K. D., Terranova M. P., Schreiber S. L., Verdine G. L. Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87:1990;1937-1941.
21. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 polymerase to direct expression of cloned genes. Methods Enzymol. 185:1990;60-89.
22. Nagai K., Thogersen H. C. Synthesis and sequence specific proteolysis of hybrid proteins produced inE. coli. Methods Enzymol. 153:1987;461-481.
23. Lamb J. R., Green N. Analysis of the antigen specificity of influenza haemagglutinin-immune human T lymphocyte clones: Identification of an immunodominant region for T cells. Immunology. 50:1983;659-666.
24. Roche P. A., Cresswell P. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J. Immunol. 144:1990;1849-1856.
25. Sinigaglia F., Guttinger M., Kilgus J., Doran D. M., Matile H., Etlinger H., Trzeciak A., Gillessen D., Pink J. R. L. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature. 336:1988;778-779.
26. Lampson L. A., Levy R. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:1980;293-299.
27. Gorga J. C., Knudsen P. J., Foran J. A., Strominger J. L., Burakoff S. J. Immunochemically purified DR antigens in liposomes stimulate xenogenic cytolytic T cells in secondaryin vitro. Cell. Immunol. 103:1986;160-173.
28. Hunter W. M., Greenwood F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 194:1962;495-496.
29. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
30. Sanchez-Ruiz J. M. Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. Biophys. J. 61:1992;921-935.
31. Becktel W. J., Schellman J. A. Protein stability curves. Biopolymers. 26:1987;1859-1877.
32. Privalov P. L., Gill S. J. Adv. Protein Chem. 39:1988;191.
33. Buchner J., Rudolph R. Renaturation, purification and characterization of recombinant F-ab fragments produced inE. coli. Biotechnology. 9:1991;157-162.
34. Garboczi D. N., Hung D. T., Wiley D. C. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed inEscherichia coli. Proc. Natl. Acad. Sci. USA. 89:1992;3429-3433.
35. Goto Y., Ichimura N., Hamaguchi K. Effects of ammonium sulfate on the unfolding and refolding of the variable and constant fragments of an immunoglobulin light chain. Biochemistry. 27:1988;1670-1677.
36. Ghosh P., Amaya M., Mellins E., Wiley D. C. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 378:1995;457-462.
37. Gorga J. C., Dong A., Manning M. C., Woody R. W., Caughey W. S., Strominger J. L. Comparison of the secondary structures of humna class I and class II major histocompatibility complex antigens by Fourier transform and circular dichroism spectroscopy. Proc. Natl. Acad. Sci. USA. 86:1989;2321-2325.
38. Jardetzky T. S., Gorga J. C., Busch R., Rothbard J., Strominger J. L., Wiley D. C. Peptide binding to HLA-DR1: A peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9:1990;1797-1803.
39. Marks M. S., Germain R. N., Bonifacino J. S. Transient aggregation of major histocompatibility complex class Ii chains during assembly in normal spleen cells. J. Biol. Chem. 270:1995;10475-10481.
40. Zhong G., Castellino F., Romagnoli P., Germain R. N. Evidence that binding site occupancy is necessary and sufficient for effective MHC class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:1996;2061-2066.
41. Fahnestock M. L., Tamir I., Narhi L., Bjorkman P. J. Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science. 258:1992;1658-1662.
42. Reich Z., Altman J. D., Boniface J. J., Lyond D. S., Konono H., Ogg G., Morgan C., Davis M. M. Stability of empty and peptide-loaded class II histocompatibility complex molecules at neutral and endosomal pH: Comparison to class I proteins. Proc. Natl. Acad. Sci. USA. 94:1997;2495-2500.
43. Bouvier M., Wiley D. C. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science. 265:1994;398-402.
44. Ljunggren H. G., Stam N. J., Öhlén C., Neefjes J. J., Höglund P., Heemels M. T., Bastin J., Schumacher T. N., Townsend A., Kärre K., Ploegh H. L. Empty MHC class I molecules come out in the cold. Nature. 346:1990;476-480.
45. Rabanal F., Ludevid M. D., Pons M., Giralt E. CD of proline-rich polypeptides: Application to the study of the repetitive domain of maize glutenin-2. Biopolymers. 33:1993;1019-1028.
46. k. Nature. 337:1989;274-276.
47. Runnels H. A., Moore J. C., Jensen P. E. A structural transition in class II MHC proteins at mildly acidic pH. J. Exp. Med. 183:1996;127-136.
48. Boniface J. J., Lyons D. S., Wettstein D. A., Allbritton N. L., Davis M. M. Evidence for a conformational change in a class II major histocompatibility molecule occurring in the same pH range where antigen binding is enhanced. J. Exp. Med. 183:1996;119-126.